Use of Suprachoroidal Triamcinolone Acetonide in Pediatric Uveitis
SCS-TA injection demonstrated an adequate safety profile for pediatric patients with favorable IOP outcomes and limited adverse effects. SCS-TA may be considered for treatment of pediatric UME, retinal vasculitis, and perioperative control of inflammation in children with uveitis undergoing cataract/glaucoma surgery.
Authors
- Justin Hanson (ORCID: https://orcid.org/0000-0002-5647-7954)
- Kirk Hou (ORCID: https://orcid.org/0000-0003-1986-3327)
- Judy L. Chen (ORCID: https://orcid.org/0000-0001-6368-0064)
- Edmund Yik Kong Tsui (ORCID: https://orcid.org/0000-0001-7532-9191)
- Shani Pillar (ORCID: https://orcid.org/0000-0001-8557-5150)
- Irena Tsui (ORCID: https://orcid.org/0000-0001-7989-5174)
- Kareem Moussa (ORCID: https://orcid.org/0000-0001-9110-9594)
- S. Fung (ORCID: https://orcid.org/0000-0001-9905-636X)
- Marcus H. Yamamoto (ORCID: https://orcid.org/0000-0001-6991-6867)
- Mona Fayad (ORCID: https://orcid.org/0000-0002-0238-3207)
- Albert Liao (ORCID: https://orcid.org/0000-0002-1424-4431)
Institutions
- Doheny Eye Institute (US)
- University of California, Davis (US)
Publication Details
- Journal
- Retinal Cases & Brief Reports
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1097/icb.0000000000001801
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00